
    
      PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, multicenter study.
      Patients are randomized to receive either SYNSORB Pk or placebo.

      Patients receive oral SYNSORB Pk or placebo three times daily for 7 days. Patients are
      followed on days 7, 14, 28, and 60 after discharge from the hospital.
    
  